Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001808805-26-000023
Filing Date
2026-04-28
Accepted
2026-04-28 16:09:24
Documents
7
Period of Report
2026-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A nautilusdef14a20260617a.htm DEF 14A 601008
2 capvsnetincome-4926a.jpg GRAPHIC 49233
3 capvstsr-withoutnasdaqtsr4a.jpg GRAPHIC 57394
4 GRAPHIC nautilus2025proxycard001.jpg GRAPHIC 133829
5 nautilus2025proxycard002.jpg GRAPHIC 113791
6 nautilus_primarylogoxbluea.jpg GRAPHIC 291090
7 sujalsignaturea.jpg GRAPHIC 6720
  Complete submission text file 0001808805-26-000023.txt   1474154
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Filer) CIK: 0001808805 (see all company filings)

EIN.: 981541723 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39434 | Film No.: 26907779
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)